Prognostic value of quantitative HPV viral load in determining cervical cancer treatment response and recurrence
Prognostic value of quantitative HPV viral load in determining cervical cancer treatment response and recurrence
批准号:
10631906
负责人:
Surbhi Grover
金额:
$21.7万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-04-01 至 2025-03-31
关键词:
Acquired Immunodeficiency SyndromeAftercareBiometryBiopsyBotswanaCancer PatientCervicalCessation of lifeChemotherapy and/or radiationClinicalClinical TrialsClinical assessmentsCohort StudiesCombination Drug TherapyDetectionDevelopmentDiagnosisEarly identificationEarly treatmentEnrollmentEnsureEvaluationFoundationsFutureGoalsGrantHIVHIV InfectionsHigh PrevalenceHumanHuman Papilloma Virus-Related Malignant NeoplasmHuman PapillomavirusHuman papilloma virus infectionImageImmunologic Deficiency SyndromesIn complete remissionInterventionIntervention StudiesInvestigationLesionLocally Advanced Malignant NeoplasmMalariaMalignant NeoplasmsMalignant neoplasm of cervix uteriMentorsMethodologyMethodsModelingMolecularMonitorNatural HistoryOutcomeParentsPatient-Focused OutcomesPatientsPennsylvaniaPerformancePersonsPlayPolymerase Chain ReactionPrediction of Response to TherapyPrognostic FactorPublic HealthRadiationRadiation OncologistRadiation OncologyRecommendationRecurrenceRecurrent diseaseRecurrent tumorRegimenRelapseResearchResearch PersonnelResearch Project GrantsResource-limited settingRoleSalvage TherapySwabTestingTimeTissuesTrainingTraining and InfrastructureTreatment FailureTuberculosisTumor BurdenUniversitiesVideoconferencingViral Load resultVisitWomanWorkcancer therapycareerchemotherapyclinical careco-infectioncohortcostcost effectiveexperiencefollow-upglobal healthhigh riskimprovedimproved outcomeindividualized medicineinnovationlow and middle-income countriesmeetingsmortalitymultidisciplinaryparent grantpersonalized approachpersonalized interventionpersonalized managementpersonalized medicineprognostic toolprognostic valueprogramsrisk stratificationscreeningskill acquisitiontherapeutic HPV vaccinetooltranslational cancer researchtranslational scientisttreatment responsetumor
中文摘要
摘要
宫颈癌是全球女性最常见的癌症,中低位患者负担最高。
收入国家(LMIC)。局部晚期宫颈癌的治疗包括放疗和同期
化疗(CRT)。然而,高复发率和复发率仍然是一个重大问题,尽管
推荐的治疗方法,特别是在LMICs中。因此,确定治疗失败的高危患者
复发是发展个性化管理和对这些患者进行跟踪的关键的第一步
病人。本申请中提出的调查路线的总体目标是允许
使用风险分层模型在资源有限的环境下对宫颈癌患者进行个体化治疗。
我们相信,量化人类乳头瘤病毒(HPV)感染的负担将是有价值的
宫颈癌患者个体化管理的预后工具。更准确地说,我们假设
对HPV总负担和亚型特定负担的量化将预测治疗反应和
宫颈癌复发,使临床医生能够在最初诊断和早期对高危患者进行分层
治疗阶段。此外,定量HPV病毒载量比目前更容易获得,也更具成本效益
推荐的个性化癌症治疗方法,使其非常适合在资源有限的情况下使用
设置。在这份K08提案中,Surbhi Grover博士是一位训练有素的放射肿瘤学家,在研究宫颈方面经验丰富
LMICs中的癌症队列,将决定总HPV病毒载量和亚型特异性HPV病毒载量作为
博茨瓦纳接受CRT治疗的宫颈癌患者的治疗反应和复发的预测因子。
格罗弗博士的整个职业目标是成为一名宫颈癌翻译的独立调查员
研究和临床试验,并确定将指导所研究的个性化干预的预后因素
在未来的临床试验中,以改善LMICs中宫颈癌患者的预后。得到了来自
宾夕法尼亚大学(UPenn)放射肿瘤学系
博茨瓦纳在过去的三年里一直致力于治疗宫颈癌患者。格罗弗博士和她的多学科
导师团队制定了一项培训计划,该计划将利用我们在博茨瓦纳正在进行的研究,并使
她需要获得成为一名领先的宫颈癌翻译研究人员所需的技能,专注于
LMIC的临床试验。LMICs临床试验、高级生物统计学和分子方法方面的培训
HPV检测和量化将加强她在放射肿瘤学和公共卫生方面的培训。这个
K08拨款的拟议研究将嵌套在正在进行的博茨瓦纳大学和宾夕法尼亚大学U54
格罗弗博士目前在财团拨款方面发挥了重要作用。在K08的过程中,她将
继续以博茨瓦纳为基地实施这项研究。她将继续有常规的视频-
与她的导师举行电话会议和面对面的会议,他们将确保她在
执行这个K08项目,实现她的培训目标,推进她的整体职业目标。
英文摘要
ABSTRACT
Cervical cancer is the most common cancer in women worldwide, with the highest burden in low- and middle-
income countries (LMICs). Treatment of locally advanced cervical cancer includes radiation and concurrent
chemotherapy (CRT). However, high rates of relapse and recurrence remain a significant problem, despite
recommended treatment, particularly in LMICs. Therefore, identifying patients at high risk for treatment failure
and recurrence is a critical initial step in the development of individualized management and follow-up of those
patients. The overarching goal of the line of investigation proposed in this application is to allow for
individualized treatment of cervical cancer patients in resource-limited settings using risk stratification models.
We believe that quantification of the burden of human papillomavirus (HPV) infection will be a valuable
prognostic tool for the individualized management of cervical cancer patients. More precisely, we hypothesize
that quantification of the total and subtype-specific burden of HPV will predict treatment response and
recurrence of cervical cancer, allowing clinicians to stratify high-risk patients at initial diagnosis and early
stages of treatment. Further, quantitative HPV viral load is more accessible and cost-effective than currently
recommended approaches for individualized cancer treatment, making it ideal for use in resource-limited
settings. In this K08 proposal, Dr. Surbhi Grover, a trained radiation oncologist experienced in studying cervical
cancer cohorts in LMICs, will determine the performance of total and subtype-specific HPV viral load as a
predictor of treatment response and recurrence in cervical cancer patients treated with CRT in Botswana.
Dr. Grover's overall career goal is to became an independent investigator in cervical cancer translational
research and clinical trials, and to identify prognostic factors that will guide personalized interventions studied
in future clinical trials to improve outcomes of cervical cancer patients in LMICs. With support from the
Department of Radiation Oncology at the University of Pennsylvania (UPenn), she has been based in
Botswana for the past three years working with cervical cancer patients. Dr. Grover and her multi-disciplinary
team of mentors have developed a training plan that will leverage our ongoing studies in Botswana and enable
her to acquire the skills needed to become a leading cervical cancer translational researcher focusing on
clinical trials in LMICs. Training in clinical trials in LMICs, advanced biostatistics, and molecular methods of
HPV detection and quantification will augment her training in radiation oncology and public health. The
proposed study for the K08 grant will be nested in an ongoing University of Botswana and UPenn U54
consortia grant on which Dr. Grover currently plays a major role. During the course of the K08, she will
continue to be based in Botswana to implement this study. She will continue to have regular video-
conferencing calls and face-to-face meetings with her mentors, who will ensure that she is successful in
carrying out this K08 project, in achieving her training goals, and in advancing her overall career goals.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.jcpo.2023.100405
发表时间:
2023-03
期刊:
JOURNAL OF CANCER POLICY
影响因子:
1.3
作者:
[Koobotse, Moses O., Zachariah, Matshediso, Senabye, Bonolo, Gobe, Irene, Kadimo, Khutsafalo, Nthontho, Keneuoe C., Mokomane, Margaret, Koto, Garesego, Phuthego, Thato, Lekgetho, Henry, Ndlovu, Andrew, Motswaledi, Modisa, Mbwinja, Alfred, Tawe, Leabaneng, Ramatlho, Pleasure, Paganotti, Giacomo M., Kyokunda, Lynnete, Vuylsteke, Peter, Grover, Surbhi, Ramogola-Masire, Doreen, Kasvosve, Ishmael]
通讯作者:
Kasvosve, Ishmael
DOI:
10.1136/bmjgh-2022-009849
发表时间:
2022-11
期刊:
BMJ GLOBAL HEALTH
影响因子:
8.1
作者:
[Mutebi, Miriam, Lewison, Grant, Aggarwal, Ajay, Alatise, Olusegun Isaac, Booth, Christopher, Cira, Miska, Grover, Surbhi, Ginsburg, Ophira, Gralow, Julie, Gueye, Serine, Kithaka, Benda, Kingham, T. Peter, Kochbati, Lofti, Moodley, Jennifer, Mohammed, Sulma Ibrahim, Mutombo, Alex, Ndlovu, Ntokozo, Ntizimira, Christian, Parham, Groesbeck Preer, Walter, Fiona, Parkes, Jeannette, Shamely, Delva, Hammad, Nazik, Seeley, Janet, Torode, Julie, Sullivan, Richard, Vanderpuye, Verna]
通讯作者:
Vanderpuye, Verna
DOI:
10.1016/j.gore.2022.101032
发表时间:
2022-08
期刊:
GYNECOLOGIC ONCOLOGY REPORTS
影响因子:
1.2
作者:
[Grover, Surbhi, Luckett, Rebecca, Bhatia, Rohini K., Ralefala, Tlotlo, Seiphetlheng, Alexander, Ramogola-Masire, Doreen, Monare, Barati, Bazzett-Matabele, Lisa, Schmeler, Kathleen, Gaolebale, Ponatshego Andrew]
通讯作者:
Gaolebale, Ponatshego Andrew
DOI:
10.1016/s1470-2045(20)30316-8
发表时间:
2020-08
期刊:
The Lancet. Oncology
影响因子:
--
作者:
[Ward ZJ, Grover S, Scott AM, Woo S, Salama DH, Jones EC, El-Diasty T, Pieters BR, Trimble EL, Vargas HA, Hricak H, Atun R]
通讯作者:
Atun R
DOI:
10.1200/go.21.00312
发表时间:
2022-03
期刊:
JCO GLOBAL ONCOLOGY
影响因子:
4.5
作者:
[Gurram, Lavanya, Mohanty, Samarpita, Chopra, Supriya, Grover, Surbhi, Engineer, Reena, Gupta, Sudeep, Ghosh, Jaya, Gulia, Seema, Sawant, Sheela, Daddi, Anuprita, Deodhar, Kedar, Menon, Santosh, Rekhi, Bharat, Shylasree, T. S., Maheshwari, Amita, Mahantshetty, Umesh]
通讯作者:
Mahantshetty, Umesh
共 34 条
Thibang Diphatlha: Testing adaptive strategies to close the gap from cervical cancer diagnosis to treatment in Botswana
-
批准号:10844698
-
项目类别:
-
资助金额:$21.94万
-
财政年份:2022
-
负责人:Surbhi Grover
-
依托单位:
Thibang Diphatlha: Testing adaptive strategies to close the gap from cervical cancer diagnosis to treatment in Botswana
-
批准号:10697331
-
项目类别:
-
资助金额:$69.4万
-
财政年份:2022
-
负责人:Surbhi Grover
-
依托单位:
Thibang Diphatlha: Testing adaptive strategies to close the gap from cervical cancer diagnosis to treatment in Botswana
-
批准号:10540624
-
项目类别:
-
资助金额:$71.02万
-
财政年份:2022
-
负责人:Surbhi Grover
-
依托单位:
Prognostic value of quantitative HPV viral load in determining cervical cancer treatment response and recurrence
-
批准号:10399421
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2019
-
负责人:Surbhi Grover
-
依托单位:
Prognostic value of quantitative HPV viral load in determining cervical cancer treatment response and recurrence
-
批准号:10380979
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2019
-
负责人:Surbhi Grover
-
依托单位:
Prognostic value of quantitative HPV viral load in determining cervical cancer treatment response and recurrence
-
批准号:9901475
-
项目类别:
-
资助金额:$25.36万
-
财政年份:2019
-
负责人:Surbhi Grover
-
依托单位:
海外基金